Renowned scientist, clinician and researcher, S. Vincent Rajkumar, designated as the new chairman of the International Myeloma Foundation

S. Vincent Rajkumar By the Board of Directors of the International Myeloma Foundation (IMF), renowned scientist, clinician and researcher, S. Vincent Rajkumar, is the new chairman of the International Myeloma Foundation.

S. Vincent Rajkumar

After  Brian G.M. Durie, who is not seeking re-election to the post, Dr Rajkumar takes over from the current chairman, seeking the Chairman Emeritus and continuing to perform his recent activities. At present, he has also served as prime investigator of several clinical trials for the treatment of myeloma, including pivotal trials that led to the regulatory approval of thalidomide for the treatment of the disease in the U.S, while publishing more than 480 peer-reviewed papers primarily in the field of multiple myeloma and related plasma cell disorders. Nikhil Munshi, MD, Professor of Medicine, at Harvard Medical School, and President of the International Myeloma Society said, “Dr. Durie has admirably served the myeloma community for many decades with incredible expertise and zeal. Dr Durie’s visionary leadership has now paved the way for appointing his successor, Dr Rajkumar, as the Chair of the Board of the IMF. Dr Rajkumar, who has contributed enormously to myeloma research and clinical advancements, has been instrumental in transforming myeloma from a deadly disease into a chronic condition for most patients. His leadership brings renewed hope, promising affordable access to outstanding new treatments for patients while fostering the continued development of innovative therapies.” 

TO KNOW MORE

https://www.mayoclinic.org/biographies/rajkumar-s-vincent-m-d/bio-20053931#!

Who has been appointed as the new chairman of the International Myeloma Foundation?

Renowned scientist, clinician and researcher, S. Vincent Rajkumar has been appointed as the new chairman of the International Myeloma Foundation